Company Overview - Align Technology (ALGN) shares have increased by approximately 3.6% over the past month, underperforming the S&P 500 index [1] - The most recent earnings report is crucial for understanding the key drivers affecting the stock [1] Earnings Estimates - Estimates for Align Technology have trended downward in the past month, indicating a potential concern for future performance [2][4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the upcoming months [4] VGM Scores - Align Technology has an average Growth Score of C, a Momentum Score of D, and a Value Score of C, placing it in the middle 20% for the value investment strategy [3] - The aggregate VGM Score for Align Technology is C, which is relevant for investors not focused on a single strategy [3] Industry Performance - Align Technology is part of the Zacks Medical - Dental Supplies industry, which includes Labcorp (LH) [5] - Labcorp has experienced a 2.3% increase in shares over the past month, with reported revenues of $3.35 billion for the last quarter, reflecting a year-over-year growth of 5.3% [5] - Labcorp's earnings per share (EPS) for the last quarter was $3.84, compared to $3.68 a year ago, and it is expected to post earnings of $4.12 per share for the current quarter, indicating a 4.6% increase from the previous year [6]
Align Technology (ALGN) Up 3.6% Since Last Earnings Report: Can It Continue?